|
Alimera
Sciences, Inc.
Therapeutics for degenerative eye diseases.
|
|
|
|
Ascenta Therapeutics, Inc.
Innovative therapeutics for cancer. |
|
|
Cardiac
Pathways Corporation
Minimally invasive systems for cardiac tachyarrhythmias.
Acquired by Boston Scientific |
|
|
|
Cellective
Therapeutics, Inc.
Monoclonal antibody therapies for cancer. Acquired
by MedImmune |
|
|
Converge
Medical, Inc.
Minimally invasive cardiac surgery solutions. |
|
|
|
Corixa Corporation
Developer of immunotherapeutics. Acquired by GlaxoSmithKline
|
|
|
Coulter
Pharmaceutical, Inc.
Monoclonal antibodies for the treatment of cancer. Acquired
by Corixa |
|
|
|
CV Therapeutics,
Inc.
Drugs for chronic cardiovascular disease. (NASDAQ: CVTX) |
|
|
Dynavax
Technologies Corporation
DNA based therapeutics. (NASDAQ: DVAX) |
|
|
|
La Jolla
Pharmaceuticals Company
Therapeutics for autoimmune disease. (NASDAQ: LJPC) |
|
|
Orexigen Therapeutics, Inc.
Biopharmaceuticals for obesity. (NASDAQ: OREX) |
|
|
|
Prestwick
Pharmaceuticals, Inc.
Therapeutics for the central nervous system disorders.
|
|
|
RITA Medical
Systems, Inc.
Devices which use R.F. energy to ablate cancerous tumors. Acquired by AngioDynamics
|
|
|
|
Seattle
Genetics, Inc.
Monoclonal antibody-based therapeutics. (NASDAQ: SGEN) |
|
 |
Somaxon
Pharmaceuticals, Inc.
Specialty pharmaceutical products to treat psychiatric and related
conditions. (NASDAQ: SOMX) |
|
|
| Sonexa Therapeutics |
Sonexa
Therapeutics
Therapeutics for Alzheimer's disease. |
|
 |
Songbird
Medical, Inc.
Disposable hearing aids. |
|
|
 |
Spinal Kinetics
Innovative products for spinal surgery. |
|
 |
Vical, Inc
Gene-based pharmaceuticals. (NASDAQ: VICL)
|
|
|
 |
Zogenix, Inc.
Treatments for central nervous system disorders and pain. |
|
